Life Sciences Review

About Us

Conference

Partner With Us

BioTech Startups

Rapid Technological Advances Shaping BioTech Industries

Lukasz Swiercz,

Founder and Managing Partner

LT Capital

The Dark Side of the Genome Transforming RNA Therapies

Samir Ounzain

Scientist, regulatory RNAs

HAYA Therapeutics

Featured Issue

The Imperative Need for BI and CDS Tech in Healthace

Denise Juliano, Group Vice President of Life Sciences, Premier Inc.

Startups In The Coronavirus Era: The Acceleration Of Online Fundraising

Tai Nicolopoulos, Head of Marketing, SeedInvest

Rising Biotech Innovations to Address Indonesia's Healthcare Problems

Avina Sugiarto, Venture Partner, East Ventures

Factors to Employ Whilst Evaluating a Business Prospect

Shahin Farshchi, Partner, Lux Capital

Supporting Entrepreneurs from Early Stage to Growth Level

Pierre Socha, Partner at Amadeus Capital Partners.

How to Systematically Attain Pharma and Medtech VC Funding

Florent Gros, Venture Partner Health Fund II,at Earlybird Venture Capital

The Next Technological Advancement in Resin Development

Sofie Stille, Vice President of Technology,

Cytiva

News

Clinical-Stage Drug Developers Face Greater Pressure Around Development Planning in Europe

European Pharma Buyers Are Looking More Closely at What Development Services Actually Cover

Handoffs Could Become a Weak Point as Clinical Development Programs Expand

CRO Solutions Reshape Europe's Clinical Development Landscape

From Lab to Impact: The Unyielding Promise of Science-Based Startups

Jenny Engerfelt, Investment Director, Voima Ventures

Unlocking the Potential: Swiss Pension Funds' Untapped Opportunity in Venture Capital

Simon Enderli, CEO, Swiss Entrepreneurs Foundation

The Club Degli Investitori: Turin Startup Ecosystem

Andrea Rota, Managing Director, Club degli Investitori

Investing In Industrial Biotech Startups

Almudena Trigo, founding partner and Chairwoman at BeAble Capital

Specials